Chris Hannay: Rising Demand for Immunoglobulin Driving Plasma Industry Growth in Canada
Chris Hannay, Health and Business Reporter at The Globe and Mail, shared a post on LinkedIn:
“I’ve written a few stories over the years about commercial plasma collectors coming to Canada.
But there are some numbers in the industry that I think are pretty surprising.
Here are a few.
- $1-billion: The amount Canadian Blood Services spent on plasma protein and related products last year. (This is almost two-thirds of its budget.)
- 1%: The amount of plasma collected by Canadian Blood Services that was used for transfusion. (The rest was sent to commercial partners to be processed into other pharmaceutical products, especially immunoglobulin.)
- 3: Canada is the third-highest-per-capita user of immunoglobulin in the world.
- 50%: How much demand for immunoglobulin is expected to grow over the next five years, according to Canadian Blood Services.
This huge demand for and spending on immunoglobulin has been underpinning the growth of commercial plasma collection and manufacturing in Canada in recent years.
I explain it all in a new story today that is a bit heavier than usual on numbers and charts:
Of course, whether things can continue to grow as they have is another question. I also talk to some people (Choosing Wisely Canada) working on how to use these resources most appropriately.
Thanks to Peter Jaworski (who recently launched a research group for plasma at Georgetown University) for tracking down some of the data.”
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury
-
Aug 14, 2026, 10:49Pablo Corral: Can One Infusion Lower LDL for Years
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children